NuVasive Inc. (NSDQ:NUVA) announced that its PCM cervical disc system was implanted in the 1st U.S. patient, with treatment occurring in Orlando, Fla.
The San Diego-based medical device company’s PCM cervical disc implant, which won FDA pre-market approval in October, is designed to preserve motion in the cervical spine, in lieu of a standard fusion procedure.
"We are very pleased with the initial surgeon interest in this innovative technology. The 1st U.S. training courses at the NuVasive East and West coast-based facilities are solidly booked," chairman & CEO Alex Lukianov said in prepared remarks. "The device is a differentiated, game changing solution for the cervical spine, and marks NuVasive’s foray into an exciting, rapidly growing market."
The surgeon proctors at NuVasive’s facilities will lead training courses that are scheduled to begin next month, according to the press release.
Lukianov said the implant is expected to bring $3.5-$5 million in revenue next year.